Pacific Biosciences of California, Inc. (PACB)
1.285
-0.06
(-4.81%)
USD |
NASDAQ |
Aug 24, 16:00
1.33
+0.04
(+3.50%)
After-Hours: 20:00
Pacific Biosciences of California Total Liabilities (Quarterly) : 785.06M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 785.06M |
| March 31, 2026 | 780.00M |
| December 31, 2025 | 778.73M |
| September 30, 2025 | 767.07M |
| June 30, 2025 | 763.98M |
| March 31, 2025 | 769.15M |
| December 31, 2024 | 753.85M |
| September 30, 2024 | 996.93M |
| June 30, 2024 | 1.017B |
| March 31, 2024 | 1.021B |
| December 31, 2023 | 1.045B |
| September 30, 2023 | 1.135B |
| June 30, 2023 | 1.206B |
| March 31, 2023 | 1.204B |
| December 31, 2022 | 1.204B |
| September 30, 2022 | 1.192B |
| June 30, 2022 | 1.194B |
| March 31, 2022 | 1.202B |
| December 31, 2021 | 1.216B |
| September 30, 2021 | 1.193B |
| June 30, 2021 | 987.54M |
| March 31, 2021 | 972.34M |
| December 31, 2020 | 78.49M |
| September 30, 2020 | 170.82M |
| June 30, 2020 | 172.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 174.36M |
| December 31, 2019 | 93.07M |
| September 30, 2019 | 95.10M |
| June 30, 2019 | 94.83M |
| March 31, 2019 | 90.73M |
| December 31, 2018 | 56.21M |
| September 30, 2018 | 51.03M |
| June 30, 2018 | 51.58M |
| March 31, 2018 | 54.21M |
| December 31, 2017 | 57.98M |
| September 30, 2017 | 56.50M |
| June 30, 2017 | 62.04M |
| March 31, 2017 | 66.32M |
| December 31, 2016 | 53.22M |
| September 30, 2016 | 51.96M |
| June 30, 2016 | 53.30M |
| March 31, 2016 | 51.40M |
| December 31, 2015 | 57.57M |
| September 30, 2015 | 58.41M |
| June 30, 2015 | 62.93M |
| March 31, 2015 | 65.95M |
| December 31, 2014 | 69.57M |
| September 30, 2014 | 68.61M |
| June 30, 2014 | 69.23M |
| March 31, 2014 | 65.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Illumina, Inc. | 3.812B |
| Agilent Technologies, Inc. | 5.943B |
| Bio-Rad Laboratories, Inc. | 3.078B |
| Danaher Corp. | 39.78B |
| Thermo Fisher Scientific, Inc. | 60.37B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 751.85M |
| Shareholders Equity (Quarterly) | -33.21M |
| Debt to Equity Ratio | -21.26 |
| Current Ratio | 4.922 |
| Net Debt Paydown Yield | -0.27% |